Aging and multiple sclerosis
SA Sanai, V Saini, RHB Benedict… - Multiple Sclerosis …, 2016 - journals.sagepub.com
The life expectancy and average age of persons with multiple sclerosis (MS) have increased
significantly during the last two decades. The introduction of disease-modifying therapies …
significantly during the last two decades. The introduction of disease-modifying therapies …
Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis
M Langeskov-Christensen, M Heine, G Kwakkel… - Sports Medicine, 2015 - Springer
Background Aerobic capacity (VO 2max) is a strong health and performance predictor and is
regarded as a key physiological measure in the healthy population and in persons with …
regarded as a key physiological measure in the healthy population and in persons with …
[HTML][HTML] Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial
V Yadav, G Marracci, E Kim, R Spain… - Multiple sclerosis and …, 2016 - Elsevier
Background The role that dietary interventions can play in multiple sclerosis (MS)
management is of huge interest amongst patients and researchers but data evaluating this is …
management is of huge interest amongst patients and researchers but data evaluating this is …
Advances in the understanding and management of chronic pain in multiple sclerosis: a comprehensive review
I Urits, L Adamian, J Fiocchi, D Hoyt, C Ernst… - Current pain and …, 2019 - Springer
Abstract Purpose of Review Multiple sclerosis (MS) is an autoimmune disorder of the central
nervous system that can lead to severe physical, cognitive, and neurological deficits that …
nervous system that can lead to severe physical, cognitive, and neurological deficits that …
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …
[PDF][PDF] Overview and diagnosis of multiple sclerosis
SF Hunter - Am J Manag Care, 2016 - academia.edu
Multiple sclerosis (MS), a chronic inflammatory disease of unknown etiology, involves an
immunemediated attack of the central nervous system (CNS) that produces demyelination …
immunemediated attack of the central nervous system (CNS) that produces demyelination …
Diagnosis and management of progressive multiple sclerosis
G Macaron, D Ontaneda - Biomedicines, 2019 - mdpi.com
Multiple sclerosis is a chronic autoimmune disease of the central nervous system that results
in varying degrees of disability. Progressive multiple sclerosis, characterized by a steady …
in varying degrees of disability. Progressive multiple sclerosis, characterized by a steady …
[HTML][HTML] Bone fracture nonunion rate decreases with increasing age: a prospective inception cohort study
Background Fracture nonunion risk is related to severity of injury and type of treatment, yet
fracture healing is not fully explained by these factors alone. We hypothesize that patient …
fracture healing is not fully explained by these factors alone. We hypothesize that patient …
People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and …
D Amtmann, AM Bamer, J Kim, H Chung… - Disability and health …, 2018 - Elsevier
Background Individuals with multiple sclerosis (MS) report fatigue, pain, depression,
cognitive difficulties, and other symptoms. It is often difficult to compare symptoms across …
cognitive difficulties, and other symptoms. It is often difficult to compare symptoms across …
Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada
J Widdifield, NM Ivers, J Young… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background: Few studies have assessed the accuracy of administrative data for identifying
multiple sclerosis (MS) patients. Objectives: To validate administrative data algorithms for …
multiple sclerosis (MS) patients. Objectives: To validate administrative data algorithms for …